deltatrials
Completed OBSERVATIONAL NCT05289583

Impact of Therapeutic Alliance on Dropout in a Naturalistic Sample of Patients With Borderline Pathology Receiving Residential DBT (DBT_dropout2)

Sponsor: Evangelisches Krankenhaus Bielefeld gGmbH

Updated 4 times since 2022 Last updated: Mar 21, 2022 Started: Jan 1, 2019 Primary completion: Dec 31, 2021 Completion: Feb 28, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Borderline Personality Disorder and Dropout, this trial is completed. The trial is conducted by Evangelisches Krankenhaus Bielefeld gGmbH and has accumulated 4 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Apr 2022 – ~May 2022 · 30 days · monthly snapshotCompleted~May 2022 – ~Jul 2024 · 26 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. May 2022 — Jul 2024 [monthly]

    Completed

  4. Apr 2022 — May 2022 [monthly]

    Completed

    First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Evangelisches Krankenhaus Bielefeld gGmbH
Data source: Evangelisches Krankenhaus Bielefeld gGmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations